Stratifind delivers pan-cancer molecular diagnostics that combine RNA and DNA analysis to inform treatment selection. Its RainDanceEQ test provides both prognostic and predictive insights to guide precision oncology decisions across tumor types. By unifying transcriptomic and genomic signals in a single assay, Stratifind helps clinicians choose evidence-based therapies.
Subscribe to our newsletter to stay up to date with the latest news.
